Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I listen to Jesspro.
AUPH has very bright future. Patience is the key. I believe AUPH will be my next winner. I buy and hold AUPH as I believe it will be my next winner. I always pick up the gold bags of AUPH shares whenever the price is right to me. I like cheapened gold bags.
I don't set stop loss. I don't buy on margin. I don't sell. I add more when it pulls back. What can the manipulators/shorts and their employees do to my AUPH shares and my money? Ah? AUPH has very bright future. Patience is the key. I believe AUPH will be my next winner. I buy and hold AUPH as I believe it will be my next winner. I always pick up the gold bags of AUPH shares whenever the price is right to me. I like cheapened gold bags.
AUPH CEO Glickman says $4 billion market by 2022 ( bloombergtv.ca/2017-05-18/news/phase-iii-trials-underway-for-aurinia-pharmaceuticals-lupus-drug/ ). Motley Fool: "Sky's the limit - Peak U.S. Market Value = $6 billion assuming the low end of both patient population and pricing. EU patient population = 175,000 - 250,000. Aurinia looks to be significantly undervalued." - https://www.fool.com/investing/2017/03/31/aurinia-pharmaceuticals-where-to-from-here.aspx
To those who hate AUPH/my posts:
I'm ABSOLUTELY not short. Nor am long. I'm just doing my job for income. I am employed. Please don't doubt my honesty. Everybody listened/listens to me and appreciates my biotech research on the previous winner/AUPH. Don't you?
I'm ABSOLUTELY neither long nor short. I'm just doing my job for income. I am employed. Please don't doubt my honesty. Everybody listened/listens to me and appreciates my biotech research on the previous winner/AUPH. Don't you?
I'm neither long nor short. I'm just doing my job for income. I am employed. Please don't doubt my honesty. Everybody listens to me and believes my biotech research on AUPH. Don't you?
I'm doing my job for my income. I'm ABSOLUTELY not long. Nor am I short. But I am employed. Please don't doubt my honesty. Everybody listens to me and believe my biotech research on AUPH. Don't you?
I'm ABSOLUTELY not long. Nor am I short. But I am employed. I'm doing my job for my income. Please don't doubt my honesty. Everybody listens to me and believe my biotech research on AUPH. Don't you?
I'm ABSOLUTELY NOT short. I'm not long, either. But I am employed. I'm doing my job for my income. Please don't doubt my honesity. Everybody listens to me and believe what I say about AUPH. Don't you?
"I don't set stop loss. I don't buy on margin. I don't sell. I add more when it pulls back. What can the manipulators/shorts do to my AUPH shares and my money? Ah? AUPH has very bright future. Patience is the key. I believe AUPH will be my next ARIA. I buy and hold AUPH the way I bought and held ARIA. I'm planning to add more AUPH shares now that the Glickman-Cramer interview has offered a new opportunity. I always picked/pick up the gold bags of ARIA/AUPH shares whenever the price was/is right to me. I like cheapened gold bags."
- Posted by ariadinvestor:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
Vid:"Duggan would be to Aurinia what Denner was to Ariad. Max value if he gets on the board."
Araidinvestor posted 3 months ago: ""Will Robert Duggan to Aurinia be Alex Denner to Ariad? I hope so. Robert Duggan Takes a 7.2% Stake in Aurinia (5,766,887 shares @6.50-8.85, AVG price 7.50?). This is great AUPH news to me."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
A double-blinded trial is used after initial trials show particular promise. Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
AUPH CEO Glickman says $4 billion market by 2022 ( http://bloombergtv.ca/2017-05-18/news/phase-iii-trials-underway-for-aurinia-pharmaceuticals-lupus-drug/ ). Motley Fool: "Sky's the limit - Peak U.S. Market Value = $6 billion assuming the low end of both patient population and pricing. EU patient population = 175,000 - 250,000. Aurinia looks to be significantly undervalued." - https://www.fool.com/investing/2017/03/31/aurinia-pharmaceuticals-where-to-from-here.aspx
This was posted by AI:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
Advertise Here
Vidpok: "Duggan would be to Aurinia what Denner was to Ariad. Max value if he gets on the board."
Araidinvestor posted 3 months ago: ""Will Robert Duggan to Aurinia be Alex Denner to Ariad? I hope so. Robert Duggan Takes a 7.2% Stake in Aurinia (5,766,887 shares @6.50-8.85, AVG price 7.50?). This is great AUPH news to me."
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
A double-blinded trial is used after initial trials show particular promise. Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.
A double-blinded study is used after initial studies show particular promise. Source: MedicineNet.com
http://www.medicinenet.com/script/main/art.asp?articlekey=11177
"ILJIN's Hyuek Joon Lee is on AUPH's board of directors. ILJIN knows about any of the Voclosporin stories definitely better than BR, humour412, socialidiocies and Flyingtrader. ILJIN has been being the absolutely #1 AUPH owner/investor since 2011. Why did ILJIN still acquire 20+% or 5,185,185 shares of the 25,645,000 shares offered publicly on 03-13-2017? AUPH is good, isn't it? LJIN owns 17.35% of AUPH (14,205,457 shares) now after it added 5,185,185 shares at $6.75 in March. I don't think Katrina's confidence on AUPH would be shaken by BR and humour412."
https://relationshipscience.com/hyuek-joon-lee-p157816980
Dr. Hyuek Joon Lee is the Director of New Business Development for ILJIN Group and is responsible for mergers and acquisitions, and managing overseas investments, joint ventures and subsidiaries. As of October 2014 he joined the board of directors of Life Science Enterprises in Massachusetts, ..." Link: http://insiders.morningstar.com/trading/executive-profile.action?t=0P0000BLCT&PersonId=PS0000A8VP&flag=Director&insider=Hyuek_Lee&culture=en-CA&productcode=CAN&ops=clear&cur=
This is Posted by ariadinvestor:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
"I don't set stop loss. I don't buy on margin. I don't sell. I add more when it pulls back. What can the manipulators/shorts do to my AUPH shares and my money? Ah? AUPH has very bright future. Patience is the key. I believe AUPH will be my next ARIA. I buy and hold AUPH the way I bought and held ARIA. I'm planning to add more AUPH shares now that the Glickman-Cramer interview has offered a new opportunity. I always picked/pick up the gold bags of ARIA/AUPH shares whenever the price was/is right to me. I like cheapened gold bags."
- Posted by ariadinvestor:
https://finance.yahoo.com/quote/AUPH/community?p=AUPH
MedicineNet:"Double-blinded studies are used when initial studies shows particular promise." - http://www.medicinenet.com/script/main/art.asp?articlekey=11177
Voclosporin's phase 2 trial has shown particular promise (amazingly good results). That's why its phase 3 trial is double-blinded. Aurinia has very bright future. Patience is the key to the big success of an AUPH true long's investment. A few true longs such as Jesspro, vidpok45, zzaatt, ariadinvestor and TC might own more ARIA shares than me. We had patience and they made millions on ARIA. We will make more on AUPH.